Detalles de la búsqueda
1.
Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.
Br J Cancer
; 115(9): 1048-1057, 2016 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27701387
2.
10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.
Lancet Oncol
; 19(3): 285-287, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508745
3.
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 177: 120-142, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335782
4.
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 160: 112-133, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34840026
5.
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 173: 71-90, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863108
6.
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Eur J Cancer
; 146: 115-124, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33601323
7.
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 139: 135-148, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992153
8.
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Expert Opin Drug Discov
; 12(8): 801-811, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28604107
9.
How to address challenges and opportunities in pediatric cancer drug development?
Expert Opin Drug Discov
; 15(8): 869-872, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32421361
Resultados
1 -
9
de 9
1
Próxima >
>>